Answers are grounded in this paper and cite their sources.
Background: Plant-derived natural products are a productive antiviral scaffold source, yet secondary metabolite libraries remain underexplored against HIV-1 amid extensive target-structure redundancy. This study presents a cluster-guided framework for HIV-1 inhibitor prioritization from the KNApSAcK database. Methods: A total of 64,166 SMs were converted to SMILES and queried against BindingDB to identify reported HIV-1 integrase, protease, and reverse-transcriptase associations. A total of 295 HIV-1 protein sequences were aligned and partitioned using DPClusSBO; representative structures (6VDK, 1MUI, 6ELI) per cluster were docked against cluster-mapped SMs using SMINA. Prioritized SMs were evaluated with SwissADME and benchmarked against ChEMBL HIV-1 inhibitors. Results: Clustering resolved three non-overlapping groups (integrase, n = 135; protease, n = 117; reverse transcriptase, n = 42), mapping 285, 124, and 410 SMs, respectively. Predicted docking scores ranged from −18.91 to −4.72 kcal/mol (integrase), −26.54 to −7.87 kcal/mol (protease), and −26.83 to −4.59 kcal/mol (reverse transcriptase). ADME-prioritized reverse-transcriptase compounds scored more favorably than the matched NNRTI reference set (p < 0.001), requiring experimental confirmation of binding affinity. DUD-E enrichment validation showed strong discriminative validity for integrase and protease (ROC-AUC 0.85, 0.78) but not reverse transcriptase (ROC-AUC 0.53), consistent with weaker pose reproduction for the latter. Conclusions: The framework reduced target redundancy and computationally prioritized natural product candidates for HIV-1 as hypothesis-generating predictions requiring experimental validation.
No takes yet. Share an insight, caveat, or question.
Alqaaf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: